CSTL
Castle Biosciences·NASDAQ
--
--(--)
--
--(--)
4.54 / 10
Netural
Analyst sentiment is overwhelmingly bullish—both of the two active analysts rate the stock ‘Strong Buy’—yet their historical win rates are modest (0.0% for Lake Street; 50.0% for Guggenheim). Fund-flow data echo a more positive tone: the medium-size bucket shows a 0.5021 inflow ratio with a positive trend, while overall and block flows lean slightly negative. This divergence suggests institutional caution but retail or mid-cap accumulation. In short, the street is optimistic, but capital movements hint at selective conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionGuggenheim
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for CSTL?
- CSTL holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.54/10 (Netural).
